H.C. Wainwright Starts Proteon Therapeutics (PRTO) at Buy

September 22, 2016 7:17 AM EDT Send to a Friend
H.C. Wainwright initiated coverage on Proteon Therapeutics (NASDAQ: PRTO) with a Buy rating and a price target of $18. Analyst ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login